课题基金 / 基金详情

项目摘要

项目成果

William Janssen的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Macrophages are known to undergo apoptosis during the resolution of inflammation in the lungs, however the mechanisms that regulate macrophage cell death are not known. The appropriate time frame during which macrophages must be removed to resolve inflammation and complete tissue repair also remains unknown. Addressing these gaps in knowledge is of significant importance since persistence of macrophages in inflammatory lesions is associated with tissue injury, abnormal tissue repair and even fibrosis. Our data show that activation of the death receptor, Fas, drives the apoptosis of recruited macrophages in self-limited models of acute lung injury and that macrophage apoptosis is reduced in non-resolving models of acute lung injury (ALI). Based on our preliminary data, we hypothesize that the anti-apoptotic molecule, cellular FLICE inhibitory protein (c-FLIP) is a critical regulator of macrophage apoptosis, and that c-FLIP prevents appropriately timed macrophage apoptosis in non-resolving forms of acute lung injury. This hypothesis will be tested in mouse models of ALI and in macrophages obtained from human subjects with the acute respiratory distress syndrome. Mouse models of ALI will also be used to determine the optimal time during which macrophages must be cleared from the lungs to terminate inflammation and the pathologic consequences of delayed macrophage apoptosis. Achieving the aims of this proposal will provide important insights into the biologic mechanisms that regulate the termination of inflammation and affect tissue repair, paving the way for novel therapies to treat non-resolving ALI and other forms of inflammatory lung disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Aspen Lung Conference: Bridging the Gap between Innate and Adaptive Immunity in the Lung
  • 批准号:
    10469141
  • 项目类别:
  • 资助金额:
    $3.3万
  • 财政年份:
    2022
  • 负责人:
    William Janssen
  • 依托单位:
Lung Macrophage Programming in Acute Lung Injury
  • 批准号:
    10335239
  • 项目类别:
  • 资助金额:
    $95.05万
  • 财政年份:
    2018
  • 负责人:
    William Janssen
  • 依托单位:
Lung Macrophage Programming in Acute Lung Injury
  • 批准号:
    10225232
  • 项目类别:
  • 资助金额:
    $55.63万
  • 财政年份:
    2018
  • 负责人:
    William Janssen
  • 依托单位:
Lung Macrophage Programming in Acute Lung Injury
  • 批准号:
    10553701
  • 项目类别:
  • 资助金额:
    $95.05万
  • 财政年份:
    2018
  • 负责人:
    William Janssen
  • 依托单位:
国内基金
海外基金
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
  • 批准号:
    22007039
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    王黎明
  • 依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
  • 批准号:
    21172061
  • 项目类别:
    面上项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2011
  • 负责人:
    许新华
  • 依托单位: